167 related articles for article (PubMed ID: 23940673)
21. Effect of JGK-263 as a new glycogen synthase kinase-3β inhibitor on extrinsic apoptosis pathway in motor neuronal cells.
Jeon GS; Kim JE; Ahn SW; Park KS; Hong YH; Ye IH; Park JS; Kim SH; Lee KW; Kim SM; Sung JJ
Biochem Biophys Res Commun; 2013 Sep; 439(2):309-14. PubMed ID: 23899525
[TBL] [Abstract][Full Text] [Related]
22. Extrinsic Apoptosis Pathway Altered by Glycogen Synthase Kinase-3
Kim JE; Lim JH; Jeon GS; Shin JY; Ahn SW; Kim SH; Lee KW; Hong YH; Sung JJ
Biomed Res Int; 2017; 2017():4163839. PubMed ID: 29082245
[TBL] [Abstract][Full Text] [Related]
23. Genetic deletion of glycogen synthase kinase-3beta abrogates activation of IkappaBalpha kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor.
Takada Y; Fang X; Jamaluddin MS; Boyd DD; Aggarwal BB
J Biol Chem; 2004 Sep; 279(38):39541-54. PubMed ID: 15252041
[TBL] [Abstract][Full Text] [Related]
24. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
[TBL] [Abstract][Full Text] [Related]
26. Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments.
Hernández F; Borrell J; Guaza C; Avila J; Lucas JJ
J Neurochem; 2002 Dec; 83(6):1529-33. PubMed ID: 12472906
[TBL] [Abstract][Full Text] [Related]
27. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload.
Badorff C; Ruetten H; Mueller S; Stahmer M; Gehring D; Jung F; Ihling C; Zeiher AM; Dimmeler S
J Clin Invest; 2002 Feb; 109(3):373-81. PubMed ID: 11827997
[TBL] [Abstract][Full Text] [Related]
28. A myocyte enhancer factor 2D (MEF2D) kinase activated during neuronal apoptosis is a novel target inhibited by lithium.
Linseman DA; Cornejo BJ; Le SS; Meintzer MK; Laessig TA; Bouchard RJ; Heidenreich KA
J Neurochem; 2003 Jun; 85(6):1488-99. PubMed ID: 12787068
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.
Zhang F; Phiel CJ; Spece L; Gurvich N; Klein PS
J Biol Chem; 2003 Aug; 278(35):33067-77. PubMed ID: 12796505
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
Ishii T; Furuoka H; Muroi Y; Nishimura M
J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590
[TBL] [Abstract][Full Text] [Related]
31. Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer's disease.
Noh MY; Chun K; Kang BY; Kim H; Park JS; Lee HC; Kim YH; Ku S; Kim SH
Biochem Biophys Res Commun; 2013 May; 435(2):274-81. PubMed ID: 23632329
[TBL] [Abstract][Full Text] [Related]
32. Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta.
Engel T; Goñi-Oliver P; Gomez-Ramos P; Morán MA; Lucas JJ; Avila J; Hernández F
Neuroscience; 2008 Dec; 157(4):772-80. PubMed ID: 18951953
[TBL] [Abstract][Full Text] [Related]
33. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
34. The protein arginine methyltransferase PRMT5 regulates Aβ-induced toxicity in human cells and Caenorhabditis elegans models of Alzheimer's disease.
Quan X; Yue W; Luo Y; Cao J; Wang H; Wang Y; Lu Z
J Neurochem; 2015 Sep; 134(5):969-77. PubMed ID: 26086249
[TBL] [Abstract][Full Text] [Related]
35. Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cells.
Yeste-Velasco M; Folch J; Trullàs R; Abad MA; Enguita M; Pallàs M; Camins A
Neuropharmacology; 2007 Aug; 53(2):295-307. PubMed ID: 17612578
[TBL] [Abstract][Full Text] [Related]
36. Possible role of the glycogen synthase kinase-3 signaling pathway in trimethyltin-induced hippocampal neurodegeneration in mice.
Kim J; Yang M; Kim SH; Kim JC; Wang H; Shin T; Moon C
PLoS One; 2013; 8(8):e70356. PubMed ID: 23940567
[TBL] [Abstract][Full Text] [Related]
37. Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.
Duka T; Duka V; Joyce JN; Sidhu A
FASEB J; 2009 Sep; 23(9):2820-30. PubMed ID: 19369384
[TBL] [Abstract][Full Text] [Related]
38. Vulnerability of mouse cortical neurons to doxorubicin-induced apoptosis is strain-dependent and is correlated with mRNAs encoding Fas, Fas-Ligand, and metalloproteinases.
Wetzel M; Tibbitts J; Rosenberg GA; Cunningham LA
Apoptosis; 2004 Sep; 9(5):649-56. PubMed ID: 15314293
[TBL] [Abstract][Full Text] [Related]
39. Hypertonic stress activates glycogen synthase kinase 3beta-mediated apoptosis of renal medullary interstitial cells, suppressing an NFkappaB-driven cyclooxygenase-2-dependent survival pathway.
Rao R; Hao CM; Breyer MD
J Biol Chem; 2004 Feb; 279(6):3949-55. PubMed ID: 14607840
[TBL] [Abstract][Full Text] [Related]
40. Inositol synthesis regulates the activation of GSK-3α in neuronal cells.
Ye C; Greenberg ML
J Neurochem; 2015 Apr; 133(2):273-83. PubMed ID: 25345501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
